NCT01108562|WithdrawnPhase 1/2DMC
Loading search results
Sponsor study identifier
interventional
0
0 countries
N/A
Study Start
February 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2008
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
Not reported
Date not reportedThis study will focus on patients undergoing total hip arthroplasty and Loma Linda University Medical Center \& East Campus. These patients will be randomized to receive a low dose lidocaine infusion or placebo, in addition to the patient controlled analgesia pump. These groups will be compared to one another statistically to determine which group shows the safest and most satisfying pain control.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2008
Date type not reportedThis date has not been verified as actual or estimated.
August 2008
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
April 20, 2010
Actual (reported)April 22, 2010
Actual (reported)We propose to test the hypothesis that adding a low dose lidocaine infusion to patient controlled analgesia will lower the amount of opioids that these patients will receive, thereby improving patient safety while still providing adequate analgesia.
24 hours
Patients will receive a Dilaudid PCA in combination with a placebo infusion of normal saline.
Patients will be receive a Dilaudid PCA in combination with a continuous Lidocaine infusion.
Patients in the experimental group will be receiving a Lidocaine infusion at 1.33 mg/kg/hr for 24 hours postoperatively.
Patients in the control group will be receiving an infusion of normal saline for 24 hours postoperatively.
Michelle L Schlunt, MD
Loma Linda University Medical Center
0 participants (actual enrollment reported by the registry).
First Submitted
April 20, 2010
First Posted
April 22, 2010
Study Start
February 2008
Date type not reportedThis date has not been verified as actual or estimated.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
August 2008
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 6, 2015
Record last verified: 2015-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: